Detail Information of Transcriptional Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0258 Transporter Info | ||||
Gene Name | SLC2A3 | ||||
Transporter Name | Glucose transporter type 3, brain | ||||
Gene ID | |||||
UniProt ID | |||||
Transcriptional Regulation of This DT (TSR) | ||||||
---|---|---|---|---|---|---|
Class 1.1: Basic leucine zipper factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
CREB1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A3 gene in brain neuroblastoma condition | [1] | ||||
TF Protein Name |
Cyclic AMP-responsive element-binding protein 1 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glucose | |||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human neuroblastoma cells (SH-SY5Y) | |||||
Detailed Description |
Cyclic AMP-responsive element-binding protein 1 (CREB1), influenced by the exogenous estradiol, has been reported to activate the transcription of SLC2A3 gene in brain neuroblastoma condition , which leads to an increased expression of the drug transporter Glucose transporter type 3. | |||||
JUND |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [2] | ||||
TF Protein Name |
Transcription factor JunD | Transcription Factor Info | ||||
Tissue |
Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor JunD (JUND) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
Class 1.2: Basic helix-loop-helix factors |
Click to Show/Hide the Full List of 6 TF(s) Regulating This DT |
|||||
AHR |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of SLC2A3 gene in teratocarcinoma condition | [3] | ||||
TF Protein Name |
Aryl hydrocarbon receptor | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glucose | |||||
Studied Phenotype |
Teratocarcinoma [ICD11: 2C12.0Y] | |||||
Tissue |
Embryo | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Mouse teratocarcinoma cells (P19) | |||||
Detailed Description |
Aryl hydrocarbon receptor (AHR) has been reported to repress the transcription of SLC2A3 gene in teratocarcinoma condition, which leads to a decreased expression of the drug transporter Glucose transporter type 3. | |||||
HIF1A |
Click to Show/Hide to Show 3 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A3 gene in glioblastoma condition | [4] | ||||
TF Protein Name |
Hypoxia-inducible factor 1-alpha | Transcription Factor Info | ||||
Affected Drug/Substrate |
Lactate; Pyruvate | |||||
Studied Phenotype |
Glioblastoma [ICD11: 2A00.00] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human glioblastoma cells (U-87) | |||||
Detailed Description |
Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A3 gene in glioblastoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 3. | |||||
Transcriptional Phenomenon 2 |
Activation of SLC2A3 gene in health condition | [5] | ||||
TF Protein Name |
Hypoxia-inducible factor 1-alpha | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glucose | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Knee | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
C57BL/6 mice | |||||
Detailed Description |
Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A3 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 3. | |||||
Transcriptional Phenomenon 3 |
Activation of SLC2A3 gene in gestational choriocarcinoma condition | [6] | ||||
TF Protein Name |
Hypoxia-inducible factor 1-alpha | Transcription Factor Info | ||||
Studied Phenotype |
Gestational choriocarcinoma [ICD11: 2C75] | |||||
Tissue |
Trophoderm | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human gestational choriocarcinoma cells (BeWo) | |||||
Detailed Description |
Hypoxia-inducible factor 1-alpha (HIF1A) has been reported to activate the transcription of SLC2A3 gene in gestational choriocarcinoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 3. | |||||
TCF12 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [7] | ||||
TF Protein Name |
Transcription factor 12 | Transcription Factor Info | ||||
Tissue |
Brain; Embryo | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor 12 (TCF12) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
TCF3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [8] | ||||
TF Protein Name |
Transcription factor E2-alpha | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor E2-alpha (TCF3) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
TFAP4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [9] | ||||
TF Protein Name |
Transcription factor AP-4 | Transcription Factor Info | ||||
Tissue |
Blood; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-4 (TFAP4) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
TWIST1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A3 gene in health condition | [10] | ||||
TF Protein Name |
Twist-related protein 1 | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glucose | |||||
Studied Phenotype |
Heallth [ICD11: N.A] | |||||
Tissue |
Kidney | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Human kidney human embryonic kidney 293T cells (HEK 293T) | |||||
Detailed Description |
Twist-related protein 1 (TWIST1) has been reported to activate the transcription of SLC2A3 gene in health condition, which leads to an increased expression of the drug transporter Glucose transporter type 3. | |||||
Class 1.3: Basic helix-span-helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
TFAP2A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [8] | ||||
TF Protein Name |
Transcription factor AP-2-alpha | Transcription Factor Info | ||||
Tissue |
Breast | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2-alpha (TFAP2A) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
TFAP2C |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [9] | ||||
TF Protein Name |
Transcription factor AP-2 gamma | Transcription Factor Info | ||||
Tissue |
Breast; Skin | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor AP-2 gamma (TFAP2C) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
Class 2.1: Nuclear receptors with C4 zinc fingers |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NR3C1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of SLC2A3 gene in pregnancy condition | [11] | ||||
TF Protein Name |
Glucocorticoid receptor | Transcription Factor Info | ||||
Studied Phenotype |
Pregnancy [ICD11: JA00-JA2Z] | |||||
Tissue |
Trophoderm | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
human mononucleated trophoblast cell isolates | |||||
Detailed Description |
Glucocorticoid receptor (NR3C1) has been reported to repress the transcription of SLC2A3 gene in pregnancy condition, which leads to a decreased expression of the drug transporter Glucose transporter type 3. | |||||
Class 2.2: Other C4 zinc finger-type factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
GATA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [7] | ||||
TF Protein Name |
Erythroid transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Erythroid transcription factor (GATA1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
GATA4 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [8] | ||||
TF Protein Name |
Transcription factor GATA-4 | Transcription Factor Info | ||||
Tissue |
Heart | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription factor GATA-4 (GATA4) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
Class 2.3: C2H2 zinc finger factors |
Click to Show/Hide the Full List of 7 TF(s) Regulating This DT |
|||||
CTCF |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [2] | ||||
TF Protein Name |
Transcriptional repressor CTCF | Transcription Factor Info | ||||
Tissue |
Brain | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional repressor CTCF (CTCF) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
MAZ |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [9] | ||||
TF Protein Name |
Myc-associated zinc finger protein | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Myc-associated zinc finger protein (MAZ) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
SP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of SLC2A3 gene in brain neuroblastoma condition | [12] | ||||
TF Protein Name |
Transcription factor Sp1 | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Mouse neuroblastoma cells (neuro-2a) | |||||
Detailed Description |
Transcription factor Sp1 (SP1) has been reported to repress the transcription of SLC2A3 gene in brain neuroblastoma condition, which leads to a decreased expression of the drug transporter Glucose transporter type 3. | |||||
SP3 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A3 gene in brain neuroblastoma condition | [12] | ||||
TF Protein Name |
Transcription factor Sp3 | Transcription Factor Info | ||||
Studied Phenotype |
Brain neuroblastoma [ICD11: 2A00.11] | |||||
Tissue |
Brain | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
Mouse neuroblastoma cells (neuro-2a) | |||||
Detailed Description |
Transcription factor Sp3 (SP3) has been reported to activate the transcription of SLC2A3 gene in brain neuroblastoma condition, which leads to an increased expression of the drug transporter Glucose transporter type 3. | |||||
YY1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A3 gene in colon cancer condition | [13] | ||||
TF Protein Name |
Transcriptional repressor protein YY1 | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
up regulating | |||||
Experimental Material |
Human colon carcinoma isolates | |||||
Detailed Description |
Transcriptional repressor protein YY1 (YY1), influenced by the exogenous oxaliplatin, has been reported to activate the transcription of SLC2A3 gene in colon cancer condition , which leads to an increased expression of the drug transporter Glucose transporter type 3. | |||||
ZBTB7A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Repression of SLC2A3 gene in colon cancer condition | [14] | ||||
TF Protein Name |
Zinc finger and BTB domain-containing protein 7A | Transcription Factor Info | ||||
Affected Drug/Substrate |
Glucose | |||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Down regulating | |||||
Experimental Material |
Human colon adenocarcinoma cells (SW48) | |||||
Detailed Description |
Zinc finger and BTB domain-containing protein 7A (ZBTB7A) has been reported to repress the transcription of SLC2A3 gene in colon cancer condition, which leads to a decreased expression of the drug transporter Glucose transporter type 3. | |||||
ZNF384 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [2] | ||||
TF Protein Name |
Zinc finger protein 384 | Transcription Factor Info | ||||
Tissue |
Blood; Bone marrow | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Zinc finger protein 384 (ZNF384) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
Class 3.1: Homeo domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
POU2F1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [2] | ||||
TF Protein Name |
POU domain, class 2, transcription factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
POU domain, class 2, transcription factor 1 (POU2F1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
Class 3.3: Fork head / winged helix factors |
Click to Show/Hide the Full List of 2 TF(s) Regulating This DT |
|||||
FOXA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [7] | ||||
TF Protein Name |
Hepatocyte nuclear factor 3-alpha | Transcription Factor Info | ||||
Tissue |
Breast; Embryo; Liver; Lung; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Hepatocyte nuclear factor 3-alpha (FOXA1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
FOXP1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [8] | ||||
TF Protein Name |
Forkhead box protein P1 | Transcription Factor Info | ||||
Tissue |
Embryo; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Forkhead box protein P1 (FOXP1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
Class 3.5: Tryptophan cluster factors |
Click to Show/Hide the Full List of 4 TF(s) Regulating This DT |
|||||
FLI1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [7] | ||||
TF Protein Name |
Friend leukemia integration 1 transcription factor | Transcription Factor Info | ||||
Tissue |
Blood; Vein | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Friend leukemia integration 1 transcription factor (FLI1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
GABPA |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [9] | ||||
TF Protein Name |
GA-binding protein alpha chain | Transcription Factor Info | ||||
Tissue |
Blood; Liver; Prostate | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
GA-binding protein alpha chain (GABPA) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
IRF1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [8] | ||||
TF Protein Name |
Interferon regulatory factor 1 | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Interferon regulatory factor 1 (IRF1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
MYB |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [9] | ||||
TF Protein Name |
Transcriptional activator Myb | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcriptional activator Myb (MYB) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
Class 3.7: ARID domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
ARID3A |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [2] | ||||
TF Protein Name |
AT-rich interactive domain-containing protein 3A | Transcription Factor Info | ||||
Tissue |
Bone marrow; Liver | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
AT-rich interactive domain-containing protein 3A (ARID3A) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
Class 6.4: Runt domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
RUNX1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [7] | ||||
TF Protein Name |
Runt-related transcription factor 1 | Transcription Factor Info | ||||
Tissue |
Blood; Bone; Bone marrow; Umbilical cord blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Runt-related transcription factor 1 (RUNX1) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
Class 6.7: Grainyhead domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GRHL2 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [8] | ||||
TF Protein Name |
Grainyhead-like protein 2 homolog | Transcription Factor Info | ||||
Tissue |
Breast; Bronchus; Ovary | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Grainyhead-like protein 2 homolog (GRHL2) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
TF Superclass 7: beta-Hairpin exposed by an alpha/beta-scaffold |
||||||
Class 7.1: SMAD/NF-1 DNA-binding domain factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
NFIC |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [2] | ||||
TF Protein Name |
Nuclear factor 1 C-type | Transcription Factor Info | ||||
Tissue |
Blood | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Nuclear factor 1 C-type (NFIC) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
Class 8.2: A.T hook factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
HMGA1 |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Activation of SLC2A3 gene in colon cancer condition | [15] | ||||
TF Protein Name |
High mobility group protein HMG-I/HMG-Y | Transcription Factor Info | ||||
Studied Phenotype |
Colon cancer [ICD11: 2B90] | |||||
Tissue |
Colon | |||||
Related DT Changes |
Up regulating | |||||
Experimental Material |
human colon cancer cell isolates | |||||
Detailed Description |
High mobility group protein HMG-I/HMG-Y (HMGA1) has been reported to activate the transcription of SLC2A3 gene in colon cancer condition, which leads to an increased expression of the drug transporter Glucose transporter type 3. | |||||
Class 10.1: Other factors |
Click to Show/Hide the Full List of 1 TF(s) Regulating This DT |
|||||
GTF2B |
Click to Show/Hide to Show 1 Transcriptional Phenomena |
|||||
Transcriptional Phenomenon 1 |
Direct binding to SLC2A3 gene | [9] | ||||
TF Protein Name |
Transcription initiation factor IIB | Transcription Factor Info | ||||
Tissue |
Cervix; Lung | |||||
Related DT Changes |
Direct regulating | |||||
Experiment method |
TF-transporter regulations were collected from ChIP-Seq datasets. | |||||
Detailed Description |
Transcription initiation factor IIB (GTF2B) can directly bind to the SLC2A3 gene, which in turn affects the expression or function of the drug transporter Glucose transporter type 3. | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.